BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4391843)

  • 1. Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals.
    Fraser IM; Vesell ES
    Ann N Y Acad Sci; 1968 Jul; 151(2):777-94. PubMed ID: 4391843
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
    Fraser IM; Vesell ES
    J Pharmacol Exp Ther; 1968 Jul; 162(1):155-65. PubMed ID: 5656594
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of some metabolites of hemolytic drugs on young and old, normal and G-6-PD-deficient human erythrocytes.
    Fraser IM; Tilton BE; Vesell ES
    Ann N Y Acad Sci; 1971 Jul; 179():644-53. PubMed ID: 5285395
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
    Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
    Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells.
    Scott GL; Rasbridge MR
    Br J Haematol; 1973 Mar; 24(3):307-17. PubMed ID: 4713632
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose-6-phosphate dehydrogenase deficiency: mechanisms of drug-induced hemolysis.
    Hochstein P
    Exp Eye Res; 1971 May; 11(3):389-95. PubMed ID: 4941679
    [No Abstract]   [Full Text] [Related]  

  • 7. Red-cell catalase and the production of methaemoglobin, Heinz bodies and changes in osmotic fragility due to drugs.
    Tudhope GR; Leece SP
    Acta Haematol; 1971; 45(5):290-302. PubMed ID: 5000041
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of oxidized glutathione in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes and their hemolysates.
    Rieber EE; Jaffé ER
    Blood; 1970 Feb; 35(2):166-72. PubMed ID: 5414698
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced hemolysis: biochemical considerations.
    Shahidi NT
    Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of sulfamethoxypyrazine in persons with an erythrocytic glucose-6-phosphate deficiency].
    Flatz G; Voss B; Voss S
    Klin Wochenschr; 1970 Jan; 48(2):88-91. PubMed ID: 5521218
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical processes involved in ferrihemoglobin formation by monohydroxyaniline derivatives in erythrocytes of birds and mammals.
    Blaauboer BJ; van Holsteijn CW; Wit JG
    Comp Biochem Physiol C Comp Pharmacol; 1979; 62C(2):199-203. PubMed ID: 37027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of chloroquine and primaquine on red cell metabolism (author's transl)].
    Waller HD; Lüer S; Benöhr HC
    Klin Wochenschr; 1973 Dec; 51(24):1185-90. PubMed ID: 4789326
    [No Abstract]   [Full Text] [Related]  

  • 13. THE MECHANISM OF HAEMOLYSIS IN FAVISM. SOME ANALOGY IN THE ACTIVITY OF PRIMAQUINE AND FAVA JUICE.
    PANIZON F; ZACCHELLO F
    Acta Haematol; 1965 Mar; 33():129-38. PubMed ID: 14326932
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glutathione reduction in erythrocytes of healthy persons and enzyme defect carriers. Use of the azoester test by Kosower et al. in glucose-6-P-dehydrogenase and glutathione reductase deficiency].
    Waller HD; Benöhr HC; Heuer B; Nerke O
    Klin Wochenschr; 1970 Jan; 48(2):79-85. PubMed ID: 5521216
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythrocyte glucose-6-phosphate dehydrogenase and glutathione deficiency in sheep.
    Maronpot RR
    Can J Comp Med; 1972 Jan; 36(1):55-60. PubMed ID: 4258546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
    Ali NA; al-Naama LM; Khalid LO
    East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erthrocyte glucose-6-phosphate dehydrogenase deficiency-a pharmacogenetic prototype.
    Keller DF
    CRC Crit Rev Clin Lab Sci; 1970 May; 1(2):247-302. PubMed ID: 4156288
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of oxidant agents on normal and G6PD-deficient erythrocytes.
    Bashan N; Makover O; Livne A; Moses S
    Isr J Med Sci; 1980 May; 16(5):351-6. PubMed ID: 7399864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 8-aminoquinoline antimalarial agents.
    Strother A; Fraser IM; Allahyari R; Tilton BE
    Bull World Health Organ; 1981; 59(3):413-25. PubMed ID: 6976849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
    Bashan N; Peleg N; Moses SW
    Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.